Improvement of HBsAg gene-modified dendritic cell-based vaccine efficacy by optimizing immunization method or the application of β-glucosylceramide (scientific article published in January 2013)

scientific article published in January 2013

Improvement of HBsAg gene-modified dendritic cell-based vaccine efficacy by optimizing immunization method or the application of β-glucosylceramide is …

instance of (P31):

scholarly article

Q13442814

External links are

P356	DOI	10.3109/08820139.2012.744418
P698	PubMed publication ID	23323523

P2093

author name string

Wei Chen

Bing Zhang

Bo Zhou

Heping Li

Zhirong Zeng

Jianting Long

Qiangsheng Dai

Jianyong Yang

Sizhong Xing

P2860

cites work

Beta-glucosylceramide administration (i.p.) activates natural killer T cells in vivo and prevents tumor metastasis in mice

Q39377809

Activation and route of administration both determine the ability of bone marrow-derived dendritic cells to accumulate in secondary lymphoid organs and prime CD8+ T cells against tumors

Q40111834

NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells

Q40640656

Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro: mechanisms for viral immune escape

Q44518699

Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro

Q44688644

Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant

Q47384710

Spontaneous and vaccine induced AFP-specific T cell phenotypes in subjects with AFP-positive hepatocellular cancer.

Q51975009

Dendritic cell vaccine but not idiotype-KLH protein vaccine primes therapeutic tumor-specific immunity against multiple myeloma.

Q53554939

Effective induction of therapeutic antitumor immunity by dendritic cells coexpressing interleukin-18 and tumor antigen.

Q53919727

Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells.

Q54448520

Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptides

Q56994227

Hepatitis B in China

Q29031945

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

Q29619247

Abrogation of local cancer recurrence after radiofrequency ablation by dendritic cell-based hyperthermic tumor vaccine

Q33622752

Selective loss of natural killer T cells by apoptosis following infection with lymphocytic choriomeningitis virus.

Q33848840

Dendritic cell based tumor vaccination in prostate and renal cell cancer: a systematic review and meta-analysis

Q33886261

Defective presentation of the CD1d1-restricted natural Va14Ja18 NKT lymphocyte antigen caused by beta-D-glucosylceramide synthase deficiency

Q34762274

Beta-glucosylceramide: a novel method for enhancement of natural killer T lymphoycte plasticity in murine models of immune-mediated disorders

Q35761273

Genetically modified dendritic cells for cancer immunotherapy

Q36386473

Glycolipids as immune modulatory tools

Q36651981

Production of a dendritic cell-based vaccine containing inactivated autologous virus for therapy of patients with chronic human immunodeficiency virus type 1 infection

Q37099222

A strategy for making synthetic peptide vaccines

Q37217779

Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?

Q37800934

P433

issue

P921

main subject

immunization

Q1415366

P304